Loading…
Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction
There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factor...
Saved in:
Published in: | Frontiers in cardiovascular medicine 2024-06, Vol.11, p.1419001 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3 |
container_end_page | |
container_issue | |
container_start_page | 1419001 |
container_title | Frontiers in cardiovascular medicine |
container_volume | 11 |
creator | Nguyen, Maxime Putot, Alain Masson, David Cottin, Yves Gautier, Thomas Tribouillard, Laura Rérole, Anne-Laure Guinot, Pierre-Grégoire Maza, Maud Pais de Barros, Jean-Paul Deckert, Valérie Farnier, Michel Lagrost, Laurent Zeller, Marianne |
description | There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI.
Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission.
Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes.
In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation. |
doi_str_mv | 10.3389/fcvm.2024.1419001 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_123c9002e7f048d9860e8dce45bf2147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_123c9002e7f048d9860e8dce45bf2147</doaj_id><sourcerecordid>3077993395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3</originalsourceid><addsrcrecordid>eNpVkU9vEzEQxVcIRKvSD8AF-cglwX_X9gmhCmilSkgIJC7ImtizqcvuOthOoN--DglVe_LI895vZvS67jWjSyGMfTf43bTklMslk8xSyp51p5xbvaBK_Xj-qD7pzku5pU2hpFG9edmdNL-RQtrT7ufXWH6RAXxNuRCYA9nktJ5TqdGTHYxbJGkgOIdU01-cIpA4kw3UiHMt5E-sNwT8tiKZ7pKHHCKMTTFA9jWm-VX3YoCx4PnxPeu-f_r47eJycf3l89XFh-uFF9LUhZLoMQgRjEbjGQfZdmW6BzUIb61ALnvaA1txG3QwqKFXgYLqhUC0EsVZd3XghgS3bpPjBPnOJYju30fKawe5XTSiY7whKeWoBypNsKanaIJHqVYDZ1I31vsDa7NdTdg6c80wPoE-7czxxq3TzrGG5karRnh7JOT0e4uluikWj-MIM6ZtcYJq3a4Sdi9lB6nPqZSMw8McRt0-ZreP2e1jdseYm-fN4wUfHP9DFffVGqWu</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3077993395</pqid></control><display><type>article</type><title>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</title><source>Open Access: PubMed Central</source><creator>Nguyen, Maxime ; Putot, Alain ; Masson, David ; Cottin, Yves ; Gautier, Thomas ; Tribouillard, Laura ; Rérole, Anne-Laure ; Guinot, Pierre-Grégoire ; Maza, Maud ; Pais de Barros, Jean-Paul ; Deckert, Valérie ; Farnier, Michel ; Lagrost, Laurent ; Zeller, Marianne</creator><creatorcontrib>Nguyen, Maxime ; Putot, Alain ; Masson, David ; Cottin, Yves ; Gautier, Thomas ; Tribouillard, Laura ; Rérole, Anne-Laure ; Guinot, Pierre-Grégoire ; Maza, Maud ; Pais de Barros, Jean-Paul ; Deckert, Valérie ; Farnier, Michel ; Lagrost, Laurent ; Zeller, Marianne</creatorcontrib><description>There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI.
Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission.
Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes.
In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.</description><identifier>ISSN: 2297-055X</identifier><identifier>EISSN: 2297-055X</identifier><identifier>DOI: 10.3389/fcvm.2024.1419001</identifier><identifier>PMID: 38984349</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>acute myocardial infarction ; Cardiovascular Medicine ; diabetes ; endotoxemia ; inflammation ; lipopolysaccharide ; lipoprotein</subject><ispartof>Frontiers in cardiovascular medicine, 2024-06, Vol.11, p.1419001</ispartof><rights>2024 Nguyen, Putot, Masson, Cottin, Gautier, Tribouillard, Rérole, Guinot, Maza, Pais de Barros, Deckert, Farnier, Lagrost and Zeller.</rights><rights>2024 Nguyen, Putot, Masson, Cottin, Gautier, Tribouillard, Rérole, Guinot, Maza, Pais de Barros, Deckert, Farnier, Lagrost and Zeller. 2024 Nguyen, Putot, Masson, Cottin, Gautier, Tribouillard, Rérole, Guinot, Maza, Pais de Barros, Deckert, Farnier, Lagrost and Zeller</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232875/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232875/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38984349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Maxime</creatorcontrib><creatorcontrib>Putot, Alain</creatorcontrib><creatorcontrib>Masson, David</creatorcontrib><creatorcontrib>Cottin, Yves</creatorcontrib><creatorcontrib>Gautier, Thomas</creatorcontrib><creatorcontrib>Tribouillard, Laura</creatorcontrib><creatorcontrib>Rérole, Anne-Laure</creatorcontrib><creatorcontrib>Guinot, Pierre-Grégoire</creatorcontrib><creatorcontrib>Maza, Maud</creatorcontrib><creatorcontrib>Pais de Barros, Jean-Paul</creatorcontrib><creatorcontrib>Deckert, Valérie</creatorcontrib><creatorcontrib>Farnier, Michel</creatorcontrib><creatorcontrib>Lagrost, Laurent</creatorcontrib><creatorcontrib>Zeller, Marianne</creatorcontrib><title>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</title><title>Frontiers in cardiovascular medicine</title><addtitle>Front Cardiovasc Med</addtitle><description>There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI.
Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission.
Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes.
In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.</description><subject>acute myocardial infarction</subject><subject>Cardiovascular Medicine</subject><subject>diabetes</subject><subject>endotoxemia</subject><subject>inflammation</subject><subject>lipopolysaccharide</subject><subject>lipoprotein</subject><issn>2297-055X</issn><issn>2297-055X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU9vEzEQxVcIRKvSD8AF-cglwX_X9gmhCmilSkgIJC7ImtizqcvuOthOoN--DglVe_LI895vZvS67jWjSyGMfTf43bTklMslk8xSyp51p5xbvaBK_Xj-qD7pzku5pU2hpFG9edmdNL-RQtrT7ufXWH6RAXxNuRCYA9nktJ5TqdGTHYxbJGkgOIdU01-cIpA4kw3UiHMt5E-sNwT8tiKZ7pKHHCKMTTFA9jWm-VX3YoCx4PnxPeu-f_r47eJycf3l89XFh-uFF9LUhZLoMQgRjEbjGQfZdmW6BzUIb61ALnvaA1txG3QwqKFXgYLqhUC0EsVZd3XghgS3bpPjBPnOJYju30fKawe5XTSiY7whKeWoBypNsKanaIJHqVYDZ1I31vsDa7NdTdg6c80wPoE-7czxxq3TzrGG5karRnh7JOT0e4uluikWj-MIM6ZtcYJq3a4Sdi9lB6nPqZSMw8McRt0-ZreP2e1jdseYm-fN4wUfHP9DFffVGqWu</recordid><startdate>20240625</startdate><enddate>20240625</enddate><creator>Nguyen, Maxime</creator><creator>Putot, Alain</creator><creator>Masson, David</creator><creator>Cottin, Yves</creator><creator>Gautier, Thomas</creator><creator>Tribouillard, Laura</creator><creator>Rérole, Anne-Laure</creator><creator>Guinot, Pierre-Grégoire</creator><creator>Maza, Maud</creator><creator>Pais de Barros, Jean-Paul</creator><creator>Deckert, Valérie</creator><creator>Farnier, Michel</creator><creator>Lagrost, Laurent</creator><creator>Zeller, Marianne</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240625</creationdate><title>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</title><author>Nguyen, Maxime ; Putot, Alain ; Masson, David ; Cottin, Yves ; Gautier, Thomas ; Tribouillard, Laura ; Rérole, Anne-Laure ; Guinot, Pierre-Grégoire ; Maza, Maud ; Pais de Barros, Jean-Paul ; Deckert, Valérie ; Farnier, Michel ; Lagrost, Laurent ; Zeller, Marianne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute myocardial infarction</topic><topic>Cardiovascular Medicine</topic><topic>diabetes</topic><topic>endotoxemia</topic><topic>inflammation</topic><topic>lipopolysaccharide</topic><topic>lipoprotein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Maxime</creatorcontrib><creatorcontrib>Putot, Alain</creatorcontrib><creatorcontrib>Masson, David</creatorcontrib><creatorcontrib>Cottin, Yves</creatorcontrib><creatorcontrib>Gautier, Thomas</creatorcontrib><creatorcontrib>Tribouillard, Laura</creatorcontrib><creatorcontrib>Rérole, Anne-Laure</creatorcontrib><creatorcontrib>Guinot, Pierre-Grégoire</creatorcontrib><creatorcontrib>Maza, Maud</creatorcontrib><creatorcontrib>Pais de Barros, Jean-Paul</creatorcontrib><creatorcontrib>Deckert, Valérie</creatorcontrib><creatorcontrib>Farnier, Michel</creatorcontrib><creatorcontrib>Lagrost, Laurent</creatorcontrib><creatorcontrib>Zeller, Marianne</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Maxime</au><au>Putot, Alain</au><au>Masson, David</au><au>Cottin, Yves</au><au>Gautier, Thomas</au><au>Tribouillard, Laura</au><au>Rérole, Anne-Laure</au><au>Guinot, Pierre-Grégoire</au><au>Maza, Maud</au><au>Pais de Barros, Jean-Paul</au><au>Deckert, Valérie</au><au>Farnier, Michel</au><au>Lagrost, Laurent</au><au>Zeller, Marianne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</atitle><jtitle>Frontiers in cardiovascular medicine</jtitle><addtitle>Front Cardiovasc Med</addtitle><date>2024-06-25</date><risdate>2024</risdate><volume>11</volume><spage>1419001</spage><pages>1419001-</pages><issn>2297-055X</issn><eissn>2297-055X</eissn><abstract>There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI.
Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission.
Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes.
In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38984349</pmid><doi>10.3389/fcvm.2024.1419001</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2297-055X |
ispartof | Frontiers in cardiovascular medicine, 2024-06, Vol.11, p.1419001 |
issn | 2297-055X 2297-055X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_123c9002e7f048d9860e8dce45bf2147 |
source | Open Access: PubMed Central |
subjects | acute myocardial infarction Cardiovascular Medicine diabetes endotoxemia inflammation lipopolysaccharide lipoprotein |
title | Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A22%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20and%20prognostic%20value%20of%20endotoxemia%20in%20patients%20with%20acute%20myocardial%20infarction&rft.jtitle=Frontiers%20in%20cardiovascular%20medicine&rft.au=Nguyen,%20Maxime&rft.date=2024-06-25&rft.volume=11&rft.spage=1419001&rft.pages=1419001-&rft.issn=2297-055X&rft.eissn=2297-055X&rft_id=info:doi/10.3389/fcvm.2024.1419001&rft_dat=%3Cproquest_doaj_%3E3077993395%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3077993395&rft_id=info:pmid/38984349&rfr_iscdi=true |